SETD2 mutations have also been detected in osteosarcoma, myxoid liposarcoma (MLPS), and synovial sarcoma (SYN) (Sakthikumar et al., 2018), although the effect of SETD2 on the biological function of osteosarcoma has not yet been reported. Here, SETD2 is linked to synovial sarcoma.